Systemic chemotherapy (SC) before cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA).

e15179 Background: The role of SC before and after CRS/HIPEC for patients with PMCA is unclear. This study aims to explore the effect of SC prior to CRS/HIPEC on overall survival (OS) in patients with PMCA treated at a medical center specializing in peritoneal surface malignancies. Methods: A retrospective analysis of the prospective database of 344 CRS/HIPEC patients identified 102 patients with PMCA underwent only one CRS/HIPEC between...